育世博生物科技:育世博
![Acepodia 育世博生物科技股份有限公司](https://i0.wp.com/api.multiavatar.com/Acepodia+%E8%82%B2%E4%B8%96%E5%8D%9A%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8.png?apikey=viVnb6N20jclO8)
Acepodia 育世博生物科技股份有限公司
https://www.acepodia.com
關於育世博股份有限公司 ... 我們正以全球首創的免疫細胞銜接體來改變癌症治療,透過抗體細胞連結技術(ACC)來強化標靶效應,並改善在血液癌症與實體腫瘤上的安全性及泛用性。
![育世博生物科技股份有限公司](https://i0.wp.com/api.multiavatar.com/%E8%82%B2%E4%B8%96%E5%8D%9A%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%EF%BD%9C%E5%BE%B5%E6%89%8D%E4%B8%AD.png?apikey=viVnb6N20jclO8)
育世博生物科技股份有限公司
https://www.104.com.tw
育世博生物科技股份有限公司(Acepodia)專注研發新世代癌症細胞免疫療法。育世博應用其特有ACC(Antibody-Cell Conjugation)技術平台,即「抗體-細胞接合技術」,發展一 ...
![公司簡介](https://i0.wp.com/api.multiavatar.com/%E5%85%AC%E5%8F%B8%E7%B0%A1%E4%BB%8B-Acepodia+%E8%82%B2%E4%B8%96%E5%8D%9A%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8.png?apikey=viVnb6N20jclO8)
公司簡介
https://www.acepodia.com
公司名稱, 英屬開曼群島商育世博股份有限公司. 股票代號, 6976. 實收資本額, 5,669,554,280元. 公司成立日期, 106/02/15. 興櫃日期, 112/08/08.
![育世博生物科技股份有限公司](https://i0.wp.com/api.multiavatar.com/%E8%82%B2%E4%B8%96%E5%8D%9A%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8.png?apikey=viVnb6N20jclO8)
育世博生物科技股份有限公司
https://trpma.org.tw
英屬開曼群島商育世博股份有限公司( (以下簡稱育世博))為楊育民博士及蕭世嘉博士在2017年2月共同創立。董事長楊育民博士曾在瑞士羅氏大藥廠擔任全球技術營運總裁、 ...
![聯絡我們](https://i0.wp.com/api.multiavatar.com/%E8%81%AF%E7%B5%A1%E6%88%91%E5%80%91-Acepodia+%E8%82%B2%E4%B8%96%E5%8D%9A%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8.png?apikey=viVnb6N20jclO8)
聯絡我們
https://www.acepodia.com
We'd love to hear from you If you are interested in learning more about partnership and career opportunities or enrolling in our clinical trial.
![Acepodia is pioneering next](https://i0.wp.com/api.multiavatar.com/Acepodia+is+pioneering+next-generation+cell+therapy..png?apikey=viVnb6N20jclO8)
Acepodia is pioneering next
https://www.acepodia.com
育世博運用現成型可供廣大病患族群取用的ACC技術平台治療癌症疾病,以此開發創新、高效的細胞療法。 about02. 我們的獨特性. 透過釋放γδ2 T細胞與NK細胞抗癌的能力,育世博 ...
![Technology](https://i0.wp.com/api.multiavatar.com/Technology-Acepodia+%E8%82%B2%E4%B8%96%E5%8D%9A%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8.png?apikey=viVnb6N20jclO8)
Technology
https://www.acepodia.com
育世博股份有限公司採用抗體細胞連結技術(ACC)設計出強化版的細胞療法。本公司的次世代細胞療法是運用專有的免疫細胞透過抗體細胞連結技術結合創新或已知的標靶機轉, ...
![Pipeline](https://i0.wp.com/api.multiavatar.com/Pipeline-Acepodia+%E8%82%B2%E4%B8%96%E5%8D%9A%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8.png?apikey=viVnb6N20jclO8)
Pipeline
https://www.acepodia.com
Pipeline-Acepodia 育世博生物科技股份有限公司.